학술논문
Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial
Document Type
Article
Author
Winnie, Michael; Dinh, Dinh V; Seethala, Raghu; Garcia, Hiram; Pouzar, Joe; Seep, Michael; Riffer, Ernie; Bart, Belinda; Dar, Sadia; Hoppers, Melanie; Panuto, John; Rowe, Heather; Slandzicki, Alex; Wolfe, Cameron; Desantis, Donna; Baynton, Barr; Beasley, Richard L; Markowitz, Norman; Stearns, Zebediah A; Cho, Josalyn; Goisse, Marcy; Wolf, Thomas A; Kay, Jennifer; Dharan, Nila; Fitzgibbons, William; Woodruff, Mark; Bell, Todd; Lenzmeier, Thomas; Schooley, Robert; Elie, Marie-Carmelle; Winokur, Patricia; Finberg, Robert; Hurt, Christopher; Tebas, Pablo; Sattler, Fred R; Ampajwala, Madhavi; Batts, Donald; Bloch, Mark; Moore, Richard; Dwyer, Dominic; Romo-Garcia, Javier; Patrigeon, Santiago Perez; Zulueta, Ana Patricia Rodríguez; Manosuthi, Weerawat; Chetchotisakd, Ploenchan; Ruxrungtham, Kiat; Avihingsanon, Anchalee; Suwanpimolkul, Gompol; Ratanasuwan, Winai; Lupo, Sergio; Trape, Liliana; Losso, Marcelo H; Macias, Laura M; Lopardo, Gustavo; Barcelona, Laura; Mykietuk, Analia; Alzogaray, Maria F; Beigel, John H; Bao, Yajing; Beeler, Joy; Dar, Sadia M; Perez-Patrigeon, Santiago; McClure, Natalie; Bozzolo, Dawn R; Myers, Christopher; Holley, H Preston, Jr; Hoopes, Justin; Lane, H Clifford; Hughes, Michael D; Davey, Richard T
Source
In The Lancet Infectious Diseases December 2017 17(12):1255-1265
Subject
Language
ISSN
1473-3099